发明授权
- 专利标题: Quinolinyl/quinolinylalkyl-N-terminal amino hydroxy
- 专利标题(中): 喹啉基/喹啉基烷基-N-末端氨基羟基
-
申请号: US739355申请日: 1991-08-02
-
公开(公告)号: US5283250A公开(公告)日: 1994-02-01
- 发明人: Gunnar J. Hanson , John S. Baran , Dave Weissing , Mark Russell
- 申请人: Gunnar J. Hanson , John S. Baran , Dave Weissing , Mark Russell
- 申请人地址: IL Chicago
- 专利权人: G. D. Searle & Co.
- 当前专利权人: G. D. Searle & Co.
- 当前专利权人地址: IL Chicago
- 主分类号: A61K31/165
- IPC分类号: A61K31/165 ; A61K31/34 ; A61K31/343 ; A61K31/35 ; A61K31/352 ; A61K31/40 ; A61K31/403 ; A61K31/404 ; A61K31/435 ; A61K31/44 ; A61K31/47 ; A61K31/495 ; A61P9/12 ; A61P43/00 ; C07C237/10 ; C07C237/22 ; C07D209/18 ; C07D209/42 ; C07D215/48 ; C07D241/44 ; C07D307/85 ; C07D311/22 ; C07D311/24 ; C07D471/04 ; C07D215/38
摘要:
Non-peptidyl compounds characterized generally as quinolinyl/quinolinylalkyl-N-terminal amino hydroxy .beta.-amino acid derivatives are useful as renin inhibitors for treatment of hypertension. Compounds of particular interest are of the formula ##STR1## wherein R.sub.1 is selected from ##STR2## wherein each of Y and Z is independently selected from hydrido, chloro, fluoro, methoxy and dimethylamino; wherein n is a number selected from zero through four, inclusive; wherein each of R.sub.2 and R.sub.4 is independently selected from hydrido and methyl; wherein R.sub.3 is methyl or ethyl; wherein R.sub.5 is cyclohexylmethyl; wherein R.sub.6 is hydroxy; and wherein R.sub.7 is isobutyl or ethyl; or a pharmaceutically-acceptable salt thereof.
公开/授权文献
信息查询